Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Raised by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 15.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 82,347 shares of the biotechnology company’s stock after buying an additional 10,718 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.11% of Axon Enterprise worth $25,765,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Diversified Trust Co purchased a new stake in shares of Axon Enterprise in the fourth quarter worth approximately $343,000. Nordea Investment Management AB boosted its stake in shares of Axon Enterprise by 26.8% during the 4th quarter. Nordea Investment Management AB now owns 14,447 shares of the biotechnology company’s stock valued at $3,722,000 after buying an additional 3,050 shares during the period. BKM Wealth Management LLC acquired a new position in shares of Axon Enterprise in the fourth quarter worth $32,000. Dynamic Advisor Solutions LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth $226,000. Finally, Naples Global Advisors LLC acquired a new stake in Axon Enterprise during the fourth quarter valued at $258,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on AXON. Needham & Company LLC reiterated a “buy” rating and set a $400.00 price target on shares of Axon Enterprise in a report on Tuesday, May 7th. Barclays lifted their price objective on shares of Axon Enterprise from $308.00 to $381.00 and gave the company an “overweight” rating in a research note on Wednesday, May 8th. Bank of America initiated coverage on Axon Enterprise in a report on Wednesday. They set a “buy” rating and a $380.00 target price on the stock. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $375.00 target price on shares of Axon Enterprise in a research report on Tuesday, May 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $342.54.

Axon Enterprise Trading Down 3.8 %

Shares of NASDAQ AXON traded down $12.11 during midday trading on Thursday, hitting $305.67. The stock had a trading volume of 576,970 shares, compared to its average volume of 490,593. The firm has a market cap of $23.07 billion, a P/E ratio of 92.92 and a beta of 0.95. Axon Enterprise, Inc. has a fifty-two week low of $175.37 and a fifty-two week high of $329.87. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55. The company’s 50-day simple moving average is $292.44 and its 200 day simple moving average is $288.96.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The company had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. During the same quarter last year, the firm earned $0.51 EPS. The company’s revenue for the quarter was up 34.3% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current year.

Insider Activity at Axon Enterprise

In other news, President Joshua Isner sold 44,000 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the sale, the president now directly owns 275,843 shares of the company’s stock, valued at approximately $85,500,296.28. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Jeri Williams sold 308 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now directly owns 1,607 shares in the company, valued at approximately $498,282.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the sale, the president now owns 275,843 shares in the company, valued at $85,500,296.28. The disclosure for this sale can be found here. Over the last quarter, insiders sold 89,447 shares of company stock worth $27,684,677. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.